← Back to Search

Behavioural Intervention

Physical Activity for Multiple Sclerosis

N/A
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Ambulatory without an assistive device (e.g., cane)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in msis-29 scores from baseline (pre-intervention) and after 16 weeks (post-intervention)
Awards & highlights

Summary

This trial aims to determine if a 16-week remote lifestyle intervention can improve physical activity levels, fatigue, depression, anxiety, and quality of life in individuals newly diagnosed with Multiple Sclerosis (MS)

Who is the study for?
This trial is for adults over 18 who were diagnosed with Multiple Sclerosis in the last 2 years, can walk without help, have internet access, and are currently not very active. They should be relapse-free for a month, able to read English, and on disease-modifying therapy.
What is being tested?
The study tests if a 16-week program of lifestyle physical activity delivered remotely can improve physical activity levels and quality of life (QoL) compared to those who wait before starting the program.
What are the potential side effects?
Since this intervention involves increasing physical activity gradually under guidance, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can walk without needing help from a device like a cane.
Select...
I am currently on a treatment that slows my disease's progression.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in time spent in lpa from baseline (pre-intervention) and after 16 weeks (post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes in time spent in lpa from baseline (pre-intervention) and after 16 weeks (post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Activity Behavior
Physical Activity Level (Daily step count)
Physical Activity Level (Light physical activity)
+1 more
Secondary outcome measures
Anxiety
Depressive Symptoms
Fatigue Severity
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist conditionExperimental Treatment1 Intervention
Participants will receive access to a remote-delivered physical activity program for 16 weeks that includes access to electronic newsletters and regular one-on-one coaching chats (15-30 minutes) over Zoom with a behavioral coach after the follow-up assessment.
Group II: Physical activity conditionExperimental Treatment1 Intervention
Participants in this arm will receive a remote-delivered physical activity program for 16 weeks that includes access to electronic newsletters and regular one-on-one coaching chats (15 - 30 minutes) over Zoom with a behavioral coach after the baseline assessment. Throughout the 16-week period, The investigators will ask participants to wear a Fitbit (provided) for tracking daily physical activity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Waitlist condition
2007
N/A
~50

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,665 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
1,760 Patients Enrolled for Multiple Sclerosis
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top